Early results show COVID-19 pill by Chinese company can greatly lower hospitalization risk and death
CGTN, 24 Nov 2021
A #Chinese drugmaker is reporting positive test results for its COVID-19 pill. Early data from trials in Brazil appear promising, while more information is expected in the coming month. Suzhou-based Kintor Pharma started to develop the drug shortly after the initial outbreak last year. Proxalutamide is the only small-molecule oral drug treatment for #COVID-19 inpatients which has entered phase III multiregional clinical trials.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv